COMMUNIQUÉS West-GlobeNewswire
-
NeOnc Raises $15 Million At Market Adding Fuel to the Strong NEO100 Data
09/09/2026 -
Becoming Independent and Santa Rosa Junior College Partner to Bring “BI Olympics” to Santa Rosa
09/09/2026 -
Acentra Health Named a Pioneer in URAC’s Leaders in Performance Measurement Program for Case Management
09/09/2026 -
Momenta Oral & Maxillofacial Surgery Accredited by AAAHC, Recognized as a Center of Excellence
09/09/2026 -
Parity and Maine RMOMS Partnership Demonstrates New Approach to Strengthening Rural Maternity Care
09/09/2026 -
H1 Acquires Defacto Health to Strengthen Provider Network Intelligence
09/09/2026 -
Traver Strategic Holdings Acquires Apprio and Launches Varetis, Inc.
09/09/2026 -
Editas Medicine Reports Inducement Grants to New Chief Medical Officer
09/09/2026 -
ImPact Biotech Announces Completion of Treatment in Phase 3 ENLIGHTED Trial of Padeliporfin VTP in LG-UTUC and Positive Regulatory Updates
09/09/2026 -
Femasys Partners with CapexMD to Expand Patient Access to FemaSeed® Fertility Portfolio
09/09/2026 -
Silexion Therapeutics to Participate in September 2026 Industry and Investor Conferences
09/09/2026 -
SCIENTURE to Present at the H.C. Wainwright 28th Annual Global Investment Conference on September 14, 2026
09/09/2026 -
Intelligent Bio Solutions Submits FDA 510(k) Package for Intelligent Fingerprinting Drug Screening System, Seeking U.S. Market Clearance
09/09/2026 -
Syncromune® Presents SYNC-T™ Therapy: Image-Guided Cryolysis and Intratumoral Immunotherapy at CIRSE 2026
09/09/2026 -
Sysmex Europe and Cytek® Biosciences Collaborate to Expand Access to Advanced Clinical Flow Cytometry
09/09/2026 -
Quantum BioPharma Ltd. NASDAQ: QNTM) Receives FDA Clearance to Begin Trials for Historic MS Treatment
09/09/2026 -
Propanc Biopharma to Initiate World-First Phase 1b First-in-Human Study of PRP in February 2027
09/09/2026 -
IMUNON Announces Full Agenda and Speaker Lineup Ahead of 2026 R&D Day Highlighting IMNN-001 Clinical Progress
09/09/2026 -
ENvue Medical Resumes U.S. Commercial Shipments of NanoVibronix PainShield® and Begins Fulfilling Open Distributor Orders
09/09/2026
Pages